Dr. Reddy's Laboratories, a key Indian pharmaceutical player, has been banned from China's large-scale drug procurement initiatives following a critical inspection. The probe by China's NMPA revealed significant lapses in the manufacturing process of the company's ADHD medication Atomoxetine Hydrochloride. This has led to a suspension lasting until 2026, with Dr. Reddy's assessing the financial impact.

This article explores the use of Imipramine in elderly patients, providing insights on its safety, optimal dosage, and important considerations. It aims to assist caregivers and healthcare providers in understanding how to effectively manage treatment with Imipramine in older adults. Tips and facts are included to ensure the medication is used safely and effectively.